Page last updated: 2024-10-27

fluoxetine and Pituitary ACTH Hypersecretion

fluoxetine has been researched along with Pituitary ACTH Hypersecretion in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Pituitary ACTH Hypersecretion: A disease of the PITUITARY GLAND characterized by the excess amount of ADRENOCORTICOTROPIC HORMONE secreted. This leads to hypersecretion of cortisol (HYDROCORTISONE) by the ADRENAL GLANDS resulting in CUSHING SYNDROME.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Malik, O1
Westphal, B1

Other Studies

1 other study available for fluoxetine and Pituitary ACTH Hypersecretion

ArticleYear
A role for selective serotonin reuptake inhibitors in the management of residual cognitive dysfunction in pediatric Cushing's disease.
    Journal of child and adolescent psychopharmacology, 2013, Volume: 23, Issue:1

    Topics: Adolescent; Cognition Disorders; Female; Fluoxetine; Humans; Pituitary ACTH Hypersecretion; Selectiv

2013